AJP - Endocrinology and Metabolism, Vol 267, Issue 4 E507-E514, Copyright © 1994 by American Physiological Society

ARTICLES

Placental transferrin receptor in diabetic pregnancies with increased fetal iron demand

C. D. Petry, J. D. Wobken, H. McKay, M. A. Eaton, V. S. Seybold, D. E. Johnson and M. K. Georgieff
Department of Pediatrics, University of Minnesota School of Medicine, Minneapolis 55455.

Augmented fetal hemoglobin synthesis during diabetic pregnancy increases fetal iron demand. To study the effect of increased fetal iron demand on placental transferrin receptor (TR), we utilized a monoclonal antibody to localize placental TR immunoreactivity and 125I-labeled transferrin to study TR binding characteristics in 10 placentas from poorly controlled diabetic mothers with increased fetal iron demand and 10 placentas from nondiabetic mothers. The infants born to the diabetics had higher cord serum C-peptide, erythropoietin, and hemoglobin concentrations, indicating fetal hyperinsulinemia and hypoxia, with augmented erythropoiesis and iron demand. TR immunoreactivity was localized to the syncytiotrophoblast in both groups, was greater in the diabetic group, and was inversely correlated with fetal storage iron (r = -0.75; P < 0.001). Scatchard analysis of 125I transferrin binding data confirmed greater receptor number (Bmax 17.9 +/- 2.2 vs. 12.6 +/- 1.3 pM/mg protein, P = 0.05), but reduced binding affinity [dissociation constant (Kd) 7.6 +/- 0.9 vs. 5.4 +/- 0.4 nM/l, P = 0.03] in the diabetic group. The TR staining intensity, Bmax, and Kd were each correlated with cord C-peptide, suggesting either a primary or secondary role for fetal hyperinsulinemia in TR expression. This study provides in vivo evidence that fetal factors, such as iron demand or hyperinsulinemia, influence regulation of placental TR in humans. The increase in placental syncytiotrophoblastic TR expression associated with reduced cord serum ferritin concentration suggests that the fetus utilizes both increased placental iron transport and mobilization of fetal iron stores to support augmented fetal erythropoiesis.

This article has been cited by other articles:

				J. Bradley, E. A. Leibold, Z. L. Harris, J. D. Wobken, S. Clarke, K. B. Zumbrennen, R. S. Eisenstein, and M. K. Georgieff Influence of gestational age and fetal iron status on IRP activity and iron transporter protein expression in third-trimester human placenta Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R894 - R901. [Abstract] [Full Text] [PDF]

				K. O O'Brien, N. Zavaleta, S. A Abrams, and L. E Caulfield Maternal iron status influences iron transfer to the fetus during the third trimester of pregnancy Am. J. Clinical Nutrition, April 1, 2003; 77(4): 924 - 930. [Abstract] [Full Text] [PDF]

				A. Akesson, M. Berglund, A. Schutz, P. Bjellerup, K. Bremme, and M. Vahter Cadmium Exposure in Pregnancy and Lactation in Relation to Iron Status Am J Public Health, February 1, 2002; 92(2): 284 - 287. [Abstract] [Full Text] [PDF]

				R. Rao, M. de Ungria, D. Sullivan, P. Wu, J. D. Wobken, C. A. Nelson, and M. K. Georgieff Perinatal Brain Iron Deficiency Increases the Vulnerability of Rat Hippocampus to Hypoxic Ischemic Insult J. Nutr., January 1, 1999; 129(1): 199 - 206. [Abstract] [Full Text] [PDF]